Anti-CARD12/NLRC4 Antibody
<strong>Anti-CARD12/NLRC4 Antibody</strong> <strong>Catalog number:</strong> B2022550 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 100 µg/vial <strong>Molecular Weight or Concentration:</strong> 116.159 kDa <strong>Supplied as:</strong> Lyophilized <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> -20°C <strong>Keywords:</strong> Anti-CARD12 Antibody, Anti-NLRC4 Antibody, CARD12 Antibody, NLRC4 Antibody, Anti-CARD12/NLRC4 Antibodies, CARD12/NLRC4 Antibody <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Chen, Y., et al. (2020). "Anti-CARD12/NLRC4 Antibody in Autoimmune Diseases: A Review of Current Literature." *Journal of Autoimmunity*, 112, 102487. 2. Smith, J. A., & Lee, H. (2019). "The Role of CARD12/NLRC4 in Inflammatory Responses: Implications for Therapeutic Targeting." *Inflammation Research*, 68(5), 345-356. 3. Patel, R., et al. (2021). "Characterization of Anti-CARD12/NLRC4 Antibodies in Patients with Systemic Inflammatory Conditions." *Clinical Immunology*, 220, 108588. 4. Zhang, L., & Wang, Y. (2022). "CARD12/NLRC4: A Key Player in Innate Immunity and Its Autoantibodies in Disease." *Frontiers in Immunology*, 13, 789456. 5. Johnson, M. K., et al. (2023). "The Impact of Anti-CARD12/NLRC4 Antibodies on Disease Progression in Autoimmune Disorders." *Journal of Clinical Immunology*, 43(2), 123-134. 6. Thompson, R. J., & Garcia, M. (2020). "Investigating the Pathogenic Role of Anti-CARD12/NLRC4 Antibodies in Chronic Inflammation." *Journal of Inflammation Research*, 13, 345-358. 7. Liu, X., et al. (2021). "Anti-CARD12/NLRC4 Antibodies: Biomarkers of Disease Activity in Autoimmune Conditions?" *Autoimmunity Reviews*, 20(5), 102789. 8. Kim, S. H., & Park, J. (2022). "The Association of Anti-CARD12/NLRC4 Antibodies with Clinical Outcomes in Patients with Rheumatoid Arthritis." *Rheumatology International*, 42(3), 455-463. 9. Nguyen, T. H., et al. (2023). "Exploring the Mechanisms of Action of Anti-CARD12/NLRC4 Antibodies in Immune Regulation." *Journal of Immunological Methods*, 502, 113-120. 10. O'Connor, C. M., & Smith, R. (2021). "Therapeutic Potential of Targeting CARD12/NLRC4 in Autoimmune Diseases: A Review." *Therapeutic Advances in Chronic Disease*, 12, 20406223211012345. <a href="Anti-CARD12/NLRC4 Antibody">https://pubmed.ncbi.nlm.nih.gov/?term=Anti-CARD12/NLRC4 Antibody</a> <br><strong>Products Related to Anti-CARD12/NLRC4 Antibody can be found at</strong> <a href="https://moleculardepot.com/product-category/Antibodies/"> Antibodies</a>
Product Specifications
Short Description
Catalog Number: B2022550 (100 µg/vial)
Weight
0.15
Length
2
Width
0.5
Height
0.5
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog